# A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period

> **NCT00792636** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 407 (actual)

## Conditions studied

- Migraine Disorders

## Interventions

- **DRUG:** sumatriptan and naproxen sodium combination tablet
- **DRUG:** sumatriptan tablet
- **DRUG:** naproxen sodium tablet

## Key facts

- **NCT ID:** NCT00792636
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 407 (ACTUAL)
- **Last updated:** 2016-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00792636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00792636, "A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00792636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*